177 Lu-DOTATATE疗法在一个具有神经内分泌区分的抗质前列腺癌病例中
Qiaoqiao Shu, Xianjun Li1, Xi Chen
1Department of Nuclear Medicine, Weifang People's Hospital, Shandong Province, People's Republic of China.
Clinical nuclear medicine
|June 5, 2023
概括
一名患有神经内分泌前列腺癌的患者没有对Ga-PSMA PET/CT的吸收,但对F-OC PET/CT的吸收增加. 用Lu-DOTATATE治疗导致一次循环后瘤缓解和症状改善.
科学领域:
- 核医学是一种核医学.
- 在瘤学瘤学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 前列腺癌中神经内分泌的分化带来了诊断和治疗方面的挑战.
- 用-68前列腺特异性膜抗原 (Ga-68 PSMA) PET/CT进行标准成像,在这些特定情况下可能无法充分检测出所有疾病部位.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
